The increased number of mutations observed in MSI-related endometrial cancer is a result of MLH1 gene promoter hypermethylation, which leads to a deficit of DNA mismatch repair system (dMMR), and in effect the accumulation of genetic errors [228,230] (Table 1). Here, MLH1 is linked to endometrial cancer.